You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《港股》恆指半日跌32點 腦機接口概念股炒高 醫藥股弱
據報伊朗擬與以色列停火,市場觀望本周聯儲局議息會議,道指隔夜高收317點或近0.8%。港股今日(17日)高開46點後,早段先升後跌,曾升70點一度高見24,131點,惟升勢乏力下一度失守二萬四關,曾跌108點低見23,952點,中午收報24,028點,跌32點或0.13%;國指跌19點或0.23%,報8,710點;恆生科技指數跌3點或0.06%,報5,296點。大市半日成交總額1,081.23億元。 濠賭股炒高,金沙中國(01928.HK)逆市升4.8%,為表現最佳藍籌股。花旗料澳門6月首十五日賭收達100億澳門元(上周日均賭收6.86億澳門元,較本月首八日6.5億元高5%),決定上調澳門6月賭收預測至190億澳門元。此外,匯豐研究看好美高梅(02282.HK)及銀娛(00027.HK),認為高端市場持續改善成重估關鍵,美高梅半日升逾4%,銀娛升2.7%。至於永利澳門(01128.HK)亦升3.1%。 科技股方面,阿里(09988.HK)發布升級版Qwen3,全系適配蘋果MLX架構,阿里股價升1.6%。騰訊(00700.HK)升0.2%。美團(03690.HK)、快手(01024.HK)、百度(09888.HK)及萬國數據(09698.HK)各跌0.1%至0.7%。網易(09999.HK)、京東(09618.HK)、嗶哩嗶哩(09626.HK)及美圖(01357.HK)升0.1%至1.5%。穩定幣概念眾安在線(06060.HK)升4.4%。晶片股中芯(00981.HK)跌1.6%。 美股上市的腦再生科技(RGC.US)隔夜股價飆逾2.8倍,盤中多次出現熔斷,年內累計漲幅超過50倍。受消息刺激,港股腦機接口概念股升幅顯著,南京熊貓電子(00553.HK)抽高27.6%,微創腦科學(02172.HK)亦漲近17%。 車股方面,吉利(00175.HK)、比亞迪(01211.HK)、理想(02015.HK)、蔚來(09866.HK)及小鵬(09868.HK)分別跌0.2%至1.6%。小米(01810.HK)亦跌0.5%,小米YU7電池包安全方面採取多項防護措施。電池股寧德時代(03750.HK)升1.1%。鋰業股贛鋒鋰業(01772.HK)及天齊鋰業(09696.HK)各升1.2%及1.1%。 金融股方面,匯控(00005.HK)跌0.3%。港交所(00388.HK)跌逾1%。友邦(01299.HK)升0.2%。 里昂指三桶油首選中石油(00857.HK),目標價8元,中石油及中石化(00386.HK)半日齊跌1.2%,中海油(00883.HK)跌2.4%。油氣股吉星新能源(03395.HK)挫24.4%,延長石油國際(00346.HK)跌20.5%,山東墨龍(00568.HK)則升9.7%。 中國擬縮短新藥臨床試驗申請審批周期,醫藥股石藥(01093.HK)跌4.7%,綠葉製藥(02186.HK)跌7.2%,百濟神州(06160.HK)跌2.2%。翰森製藥(03692.HK)、藥明生物(02269.HK)及藥明康德(02359.HK)各跌0.4%至1.9%。中生製藥(01177.HK)跌3.6%,其TDI01混懸液新適應症被納入突破性治療藥物程序。先聲藥業(02096.HK)向NextCure授出許可權,惟股價挫一成。 周大福(01929.HK)溢價26%發可換股債淨籌87.15億元,股價半日跌7.1%,為表現最差藍籌股。 據報新世界(00017.HK)部分債權人已收到一筆美元票息,股價半日跌2.1%。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account